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Collagen is one of most abundant proteins in animals and is ubiquitous in a variety of tissues and organs. It contains a unique amino acid called hydroxyproline that constitutes approximately 9% of total amino acid residues. Collagen polypeptides possess the repeating sequence, Gly-X-Y, where X or Y is any amino acid residue, and approximately 23% of hydroxyproline in collagen occurs as a triplet, Gly-Pro-Hyp. Pro-Hyp is usually the predominant hydroxyproline peptide in urine. 1, 2) This peptide linkage originates from the sequence Gly-Pro-Hyp in the collagen molecule that has escaped complete proteolysis. 3) Gelatin, a heat-denatured product of collagen, is widely utilized as a foodstuff in the food industry, and in folk medicines in China and Europe. In order to increase its solubility and improve its smell, an enzymatic hydrolysate of gelatin, containing peptides with a mean molecular weight of 2 to 5 kDa, is currently produced on a commercial basis. Gelatin and the gelatin hydrolysate are consumed orally as health promotion agents and have been proposed to exhibit several beneficial effects. [4] [5] [6] [7] [8] [9] [10] The mechanisms for these positive and beneficial effects have yet to be clarified. Some bioactive oligopeptides may be formed through protein digestion and absorption in the intestines. In human blood, the occurrence of several Hyp-peptides has been demonstrated after oral ingestion of a gelatin hydrolysate, 11, 12) but transport of Hyp-peptide across the intestinal tract has not been directly demonstrated.
Hyp-peptides such as gelatin and gelatin hydrolysates derived from foodstuffs are expected to be resistant to hydrolysis during intestinal digestion and assimilation. The four dipeptides (Pro-Hyp, Hyp-Gly, Ser-Hyp, and Ala-Hyp) tested in this study were expected to be typical of the Hyp-peptides originating from the alpha-1 chains of the collagen sequence. Pentadecapeptide, (Pro-HypGly) 5 , has been used for a study of the stabilization of the collagen triple helix by a Hyp-containing polypeptide. 13) We therefore investigated the transport of synthetic hydroxyproline-containing dipeptides and a pentadecapeptide across the rat small intestinal tract into the blood stream using the in situ vascular perfusion technique, and identified the peptides in the perfusate by using LC-MS/MS and MALDI-TOF/MS. This study will shed light on the mechanism involved in the beneficial effects of orally an administered gelatin hydrolysate.
Materials and Methods
Chemicals. L-Hydroxyproline (L-Hyp) and the other L-amino acids were purchased from Wako Pure Chemical Industries (Osaka, Japan). Prolylhydroxyproline and -cyano-4-hydroxycinnamic acid (CHCA) y To whom correspondence should be addressed. Tel: +81-28-649-5464; Fax: +81-28-649-5155; E-mail: tanakah@cc.utsunomiya-u.ac.jp Abbreviations: Hyp, hydroxyproline; LC-MS/MS, liquid chromatography-tandem mass spectrometry; MRM, multiple-reaction monitoring; CHCA, -cyano-4-hydroxycinnamic acid; MALDI-TOF/MS, matrix assisted laser desorption time of flight mass spectrometry; TFA, trifuoroacetic acid were purchased from Sigma Chemical (St. Louis, MO, USA), and (Pro-Hyp-Gly) 5 was from Peptide Institute (Osaka, Japan). The other analytical grade chemicals and HPLC solvents were obtained from Wako Pure Chemical Industries and Merck (Darmstadt, Germany).
Peptide synthesis. The hydroxyproline-containing dipeptides, AlaHyp, Ser-Hyp and Hyp-Gly, were prepared in our laboratory from CbzAla, Cbz-Ser and Cbz-Hyp, respectively, with Hyp-benzylester . TsOH or Gly-benzylester . TsOH by a method using dicyclohexylcarbodiimide (DCC) as the coupling reagent. Cbz-amino acids and amino acids-OBzl . TsOH were synthesized as described previously.
3) The coupling products were hydrogenated for 8-10 h in the presence of Pd black, and the obtained dipeptides were crystallized or precipitated as white powder from water-ethanol-ethyl ether.
Animals and diets. Five-week-old male Wistar rats (approximately 130 g) were purchased from Charles River Japan (Kanagawa, Japan) and were individually housed in stainless-steel wire cages in a room maintained at 22 AE 2 C with a 12-h light-dark cycle. The rats were fed with a 20% casein diet for more than three days before the experiments. The 20% casein diet was prepared in our laboratory and contained 200 g of casein, 50 g of corn oil, 35 g of mineral mixture (AIN 93G), 14) 20 g of cellulose powder, 10 g of a vitamin mixture (AIN 93) and enough corn starch to reach a final weight of 1 kg. The rats were fasted overnight prior to the start of the experiments. The animal care protocol was approved by the Utsunomiya University Animal Research Committee under the Guidelines for Animal Experiments of Utsunomiya University.
Vascular perfusion of the rat small intestine. Rats were anesthetized with sodium pentobarbital (0.5 mg/100 g BW, i.p.) and fixed to a surgical platform in perfusion apparatus maintained at 37 C using a thermoregulatory-controlled heating unit. The thoracic cavity was disclosed by cutting upwards and bilaterally along the rib wall, exposing the heart. An anticoagulant was injected into the heart in advance, and a small incision was made through the apex of the left ventricle, before inserting a catheter into the aorta which was clamped into place. The portal vein was then exposed, and the return catheter was inserted into the vessel. A single-pass perfusion was established by securing the in-flow catheter in the aorta, and the perfusate was collected in an out-flow catheter of the portal vein. The exposed surface of the small intestine was covered with wet gauze and plastic film to avoid surface drying. In the previous studies, 2 to 40 mM concentrations of dipeptides had been used as substrates for the intestinal perfusion experiments. [15] [16] [17] To obtain the base-line level for the absorption, the perfusate was initially collected at two times before injecting the peptide into the gut lumen. Thus, ten minutes after beginning, 1 ml of the test peptide solution (20 mM as for Hyp) was injected into the jejunum lumen at t ¼ 0 min.
The rat small intestine was perfused vascularly with a Krebs Ringer bicarbonate solution (pH 7.4) containing 2% bovine serum albumin and 15 mM glucose. The perfusate solution was supplemented with dexamethasone and noradrenaline to counteract the effects of denervation 18) and continuously bubbled with 95% O 2 -5% CO 2 . The flow rate was adjusted to approximately 1 ml/min by achieving a blood pressure of 110-115 mm of Hg. The surgical platform and associated apparatus were prepared in our laboratory.
Assay for hydroxyproline in the perfusate. The perfusate sample collected was deproteinized by adding 30% 5-sulfosalicylic acid (SSA, a final concentration of 3% w/v) at 4 C, left overnight, and centrifuged at 3;500 Â g for 10 min. The supernatant was used for both the analysis of Hyp and LC-MS/MS. An aliquot of the supernatant was hydrolyzed in 6 N HCl at 110 C for 24 h and subsequently evaporated to dryness. The hydroxyproline content of the sample was measured both before and after hydrolysis by the method of Firschein and Shill. 19) The amount of the peptide form of Hyp was estimated by subtracting free Hyp from total Hyp.
Determination of the intestinal dipeptide hydrolysis activity. The rat small intestine hydrolysis activity toward the Hyp containing dipeptides was measured. Intestinal epithelial cells were collected by slideglass scraping and homogenized with 9 volumes of an ice-cold 3 mM Tris-HCl buffer (pH 7.4) containing 0.25 M sucrose and 0.1 mM EDTA. The homogenate fraction was centrifuged at 100;500 Â g for 60 min, and the cytosol fraction was obtained. 20) The enzyme solution from cell fractionation was incubated with dipeptide as a substrate (5 mM) in a 10 mM Tris-HCl buffer (pH 8.0) for 30 min at 37 C. The reaction was terminated by adding 10% sulfosalicylic acid, and the precipitated protein was removed by centrifugation. Free Hyp in the fluid was determined by the color reaction as already described. The dipeptides used as the substrates (5 mM) were not colored by this assay. The protein content of the enzyme solution was determined by the Lowry method. 21) Analysis of the perfusate by LC-MS/MS. The perfusate from each dipeptide group was pooled, lyophilized and then applied to a cationexchange column (Dowex 50 Â 8, H þ , 200 mesh, 1 Â 3 cm) to remove the salts. The column was washed with 10 ml of 0.1 N acetic acid and subsequently eluted with 20 ml of 3 N ammonia to obtain the small peptide fraction. The peptide fraction eluted was immediately applied to HPLC (U980 instrument; Jasco, Tokyo, Japan) fitted with an ODS (C18) column (Mightysil RP-18, 2 Â 250 mm, 5 mm; Kanto Chemicals Co., Tokyo, Japan). The mobile phase was 0.2% formic acid in water (v/v) and was changed to 100% acetonitrile 10 min after the injection. The column was then washed with 100% acetonitrile for 10 min to elute all the injected materials. The flow rate was 0.2 ml/min, and the column temperature was maintained at 40 C. Mass spectrometry was performed with a Quattro LC mass spectrometer (Micromass, Manchester, UK) equipped with an electro-spray source. Both the drying gas and nebulizing gas were nitrogen generated from pressurized air by an N2G nitrogen generator (ParkerHanifin Japan, Tokyo, Japan). The nebulizer gas flow was set to approximately 100 l/h, and the desolvation gas flow to 500 l/h. The interface temperature was set to 400 C, and the source temperature to 150 C. The capillary and cone voltage were adjusted for each molecule in the ionization mode (positive). MS/MS experiments were conducted using argon as the collision gas, and the collision energy was optimized for each compound. The collision gas pressure was 0.15 Pa. Data acquisition and analyses were performed by using MassLynx software (ver. 4.1). All of these dipeptides afforded protonated ions ½M þ H þ under the experimental conditions. For Pro-Hyp, Ser-Hyp and Ala-Hyp, the major fragment ion produced by collision-induced dissociation (CID) was protonated Hyp at m=z 132. In the case of Hyp-Gly, a fragment ion at m=z 86, formed by the loss of CO 2 H 2 , was predominant. 22) Quantification of the corresponding Hyp peptides in the perfusates by an LC-MS/MS analysis was carried out by using MRM, in which the transition of m=z 229:1 > 132:1 for Pro-Hyp, m=z 189:1 > 86:1 for Hyp-Gly, m=z 219:1 > 132:1 for Ser-Hyp and m=z 203:1 > 132:1 for Ala-Hyp was selected. The amount of the Hyp-pentadecapeptide, (ProHyp-Gly) 5 , was quantified by monitoring the transitions of m=z 1354:6 > 1144:6, 1354:6 > 820:5 and 1354:6 > 553:4.
Analysis of the perfusate by RP-HPLC and MALDI-TOF/MS.
Crude material from the pooled perfusate (not containing SSA) was subjected to solid-phase extraction (SPE) with a Sep-Pak Light C18 cartridge. The crude peptide fraction eluted with 20% acetonitrile/H 2 O containing 0.1% TFA was applied to preparative HPLC. Preparative HPLC was performed with an L-2130 pump and L-2400 detector (Hitachi High Technologies, Tokyo, Japan) in an ODS-3 column (4:6 mm Â 250 mm, 5 mm, Inertsil; GL Sciences, Tokyo, Japan). The initial mobile phase was 0.1% TFA in water (v/v) which was changed to 20% acetonitrile/H 2 O containing 0.1% TFA over 30 min. The flow rate and monitoring wavelength were adjusted to 1 ml/min and 215 nm, respectively. Six HPLC peaks (t R ¼ 17:3, 17.9, 20.9, 21.7, 24.1 and 25.7 min) were manually collected and concentrated in vacuo to furnish the semi-purified peptide fractions.
Each semi-purified peptide fraction was dissolved in 1 ml of 50% acetonitrile/H 2 O containing 0.1% TFA, mixed with a matrix solution (CHCA) saturated in 50% acetonitrile/H 2 O containing 0.1% TFA on the sample plate, and air-dried for the MALDI-TOF/MS analysis. All mass spectra were acquired with an Autoflex TOF/TOF mass spectrometer (Bruker Daltonics, Yokohama, Japan) equipped with a 337 nm pulsed nitrogen laser. The ion was accelerated at 6 kV for TOF/TOF measurements.
Statistical analysis. One-way ANOVA with Tukey's post hoc test was used for the statistical analysis. Values of p < 0:05 were considered significant. Each value is expressed as the mean AE SEM. The statistical analysis was performed with SAS software version 6.0 for the time-dependent change of Hyp content in a perfusate.
Results

Hydroxyproline level in a perfusate
To examine the basal level of endogenous Hyp in a perfusate collected from the portal vein catheter, the rat small intestine was not perfused with any substrate. When free-Hyp and Hyp-dipeptides were not injected into the jejunal lumen (the 'none' group), there was approximately 15-40 nmol/ml of free-Hyp. Only a trace amount of the peptide form of Hyp was detected. When 1 ml of 19 mM L-Hyp was injected into the jejunal lumen 10 min after preliminary perfusion without any substrate, the concentration of free Hyp in the perfusate immediately increased and reached a maximum level of 400 nmol/ml after approximately 20 min (data not shown). The perfusate collected at each time did not contain a significant amount of the peptide form of Hyp, suggesting that no Hyp peptide had been formed from free Hyp injected into the lumen and/or epithelial cells of the small intestine.
The time-course characteristics of the change in free and total Hyp contents in a perfusate after injecting a test compound into the jejunal lumen are shown in Fig. 1 . Approximately 10 min after the preliminary vascular perfusion of the small intestine, a test peptide (5 mg/ml/rat) was injected into the lumen of the jejunum. The amounts of free and total Hyp in the perfusate were determined after hydrolysis by the method of Firschein and Shill. 19) In the Pro-Hyp group (Fig. 1A) , prior to injecting ProHyp into the jejunal lumen, the total Hyp content in the perfusate from the portal vein was very low, as in the basal group just described. After injecting Pro-Hyp into the lumen, free Hyp in the perfusate remained at a low level and did not increase during the vascular perfusion experimental period. The total Hyp content in the perfusate gradually increased and reached a maximum level of greater than 100 nmol/ml approximately 20 min post-injection. In the Hyp-Gly group (Fig. 1B) , the total Hyp content in the perfusate was also very low during the preliminary perfusion. After injecting Hyp-Gly into the jejunal lumen, total Hyp gradually increased and reached a maximum of 150 nmol/ml after 15 min, while free Hyp remained at a very low level throughout the perfusion period. In the Ser-Hyp group (Fig. 1C) , the total Hyp content in the perfusate increased markedly and rapidly, attaining a maximum level of 300 nmol/ml approximately 10 min post-injection. The level of free Hyp in the perfusate significantly increased to 150 nmol/ml postinjection as well. In the Ala-Hyp group (Fig. 1D) , the total Hyp content in the perfusate rapidly increased and reached a maximum level of 200 nmol/ml after approximately 10 min. The free Hyp content was very low prior to injection, but, as in the case of the Ser-Hyp group, it increased immediately after injection and attained a plateau level of 150 nmol/ml.
In the (Pro-Hyp-Gly) 5 group (Fig. 1E) , free Hyp in the perfusate remained at a low level and did not increase during the vascular perfusion experimental Table 1 ). When 1 ml of the test peptide solution (20 mM as for Hyp) was injected into the lumen, the amount of free Hyp that passed through the intestinal wall was significantly lower in the ProHyp, Hyp-Gly, and (Pro-Hyp-Gly) 5 groups (approximately 25 nmol/min) and was very similar to that seen in the 'none' group, while that in the Ser-Hyp and AlaHyp groups was markedly greater (approximately 140 nmol/min).
Significant amounts of peptide-form Hyp passed through the intestinal wall and appeared in the perfusate. Among the four dipeptides tested, the greatest amount of peptide-form Hyp was found in the perfusate obtained from the injection of Hyp-Gly. In contrast, the level of peptide-form Hyp was significantly smaller in the AlaHyp group. The group administered with Pro-Hyp showed the lowest level of total Hyp absorbed, but due to large variations in the data, there were no significant differences among the groups. The ratio of the peptide-form of Hyp to total Hyp was greater in the Pro-Hyp, Hyp-Gly, and (Pro-Hyp-Gly) 5 groups, but less in the Ala-Hyp group in which free Hyp was predominant in the perfusate.
LC-MS/MS analyses of peptides in the perfusate
The peptide fraction from each group was analyzed by LC-MS/MS operated in the positive ion mode. In the LC-MS/MS analyses, the perfusate peptide content was calculated from the increase in peak area after adding a known amount of a synthetic standard. The amounts and absorption of the Hyp-peptides thus estimated are listed in Table 2 . The highest absorption was observed for Hyp-Gly. The absorption of Pro-Hyp was markedly less than that of Hyp-Gly, and is in contrast to that seen in Table 1 . This result may reflect its low ability to be transported across the intestinal wall. When Ser-Hyp and Ala-Hyp were administered into the gut, these peptides were substantially digested and absorbed as free Hyp. However, significant amounts of these dipeptides were absorbed and appeared in the portal perfusate in the corresponding intact form. When synthetic (Pro-Hyp-Gly) 5 was injected into the intestinal lumen, a significant amount of the Hyp-dipeptide, ProHyp, was absorbed and appeared in the portal perfusate, but no Hyp-Gly was detected (Table 2) .
Hydrolase activity level in vitro
The hydrolase activity toward the four dipeptides used in the perfusion experiment was assessed by the release of the hydrolytic product, free Hyp, in the cytosol of intestinal epithelial cells (Fig. 2) . In preliminary experiments, we examined the subcellular localization of the hydrolysis activity toward these dipeptides, and found that the specific activities in the mitochondria, microsome and brush border membrane fractions were depleted, whereas the cytosolic activity was enriched approximately two to ten times as compared to that of the homogenate fraction. In this experiment, the hydrolysis activities for Pro-Hyp and Hyp-Gly in the cytosol were very low. The hydrolysis activities for Ser-Hyp and Ala-Hyp were high, and the specific activity for AlaHyp was approximately 100 times greater than that for Hyp-Gly. The hydrolysis activity for (Pro-Hyp-Gly) 5 was not measured.
MALDI-TOF/MS analyses of metabolites of (ProHyp-Gly) 5 in the perfusate
The perfusate from the (Pro-Hyp-Gly) 5 group was purified in a Sep Pak C18 cartridge, the crude peptide fraction was separated by preparative HPLC, and several fractions eluted as single peaks were analyzed by MALDI-TOF/MS. A typical example of the elution pattern from the ODS-3 column is shown in Fig. 3 . Six fractions eluted after 16 min afforded one or two protonated ions, ½M þ H þ , while the fractions eluted from 0 to 16 min gave no protonated ions in the MALDI-TOF/MS analyses. The Hyp-pentadecapeptide eluted in Each values is expressed as the mean AE SEM (n ¼ 3). Means in a column with a superscript without a common letter differ, p < 0:05. The statistical evaluation was analyzed by one-way ANOVA with Tukey's post hoc test. fraction No. 6 was identified by comparing its retention time and MALDI-TOF/TOF spectrum with those of the synthetic standard. In addition, six Hyp-oligopeptides derived from (Pro-Hyp-Gly) 5 were identified in the perfusate as Gly-(Pro-Hyp-Gly) 4 , (Pro-Hyp-Gly) 4 , Gly-(Pro-Hyp-Gly) 3 , (Pro-Hyp-Gly) 3 , Gly-(Pro-Hyp-Gly) 2 , and (Pro-Hyp-Gly) 2 as shown in Table 3 . These Hypcontaining oligopeptide derivatives in the perfusate could not be quantified by LC-MS/MS as the corresponding authentic standards were not available.
Discussion
This study demonstrated that a significant amount of peptide-form Hyp was absorbed and entered the portal vein when typical synthetic Hyp-dipeptides (Pro-Hyp, Hyp-Gly, Ser-Hyp and Ala-Hyp) and pentadecapetide ((Pro-Hyp-Gly) 5 ) were administered into the jejunum in a vascularly perfused rat small intestine in situ. Furthermore, the presence of the intact forms of these dipeptides and pentadecapeptide in the perfusate was confirmed by LC-MS/MS analyses. This is the first report of the application of MRM for the analysis of smaller Hyp-peptides transported across the intestinal wall.
Collagen contains many corresponding fragments which can be released during in vivo degradation and excreted in urine.
1-3) Szymanowics et al. 2) have reported that, of the Hyp peptides, more than 78 varieties are present in human urine, suggesting that they originate from the alpha chains of collagen as endogenous precursors and are resistant to hydrolysis in tissues and organs. 2, 23) It has previously been demonstrated that Pro-Gly and Gly-Pro were poorly hydrolyzed by brush border membranes in intestine epithelial cells 24) and that both dipeptides may be absorbed by different peptide transport systems. 15, 24) Moreover, dipeptidyl aminopeptidase IV is known as a proline-specific peptidase associated with the intestinal brush border membrane, 25) and prolyl peptides are efficiently and sequentially hydrolyzed from the carboxyl terminus by the combined action of angiotensin-converting enzyme and carboxypeptidase P. 16) These enzymes may play an important role in the digestion and assimilation of prolinecontaining peptides by the intestines.
Since little information was available regarding the hydrolysis of Hyp-containing dipeptides in the rat small intestine, we measured the hydrolysis activity toward the four dipeptides tested here. The results show that the activities against Pro-Hyp and Hyp-Gly were extremely low, while Ser-Hyp and Ala-Hyp were significantly hydrolyzed in the cytosol of intestinal epithelial cells. In the preliminary study, we also assessed the hydrolysis activities toward Hyp-dipeptides and found that their specific activities were not enriched in the mitochondrial and microsomal fractions of epithelial cells, whereas, in the cytosolic fraction, the activities were increased approximately two to four times as compared with those in the homogenate fraction (unpublished data). No enrichment of the enzyme activity against the substrates of these Hyp-dipeptides in the brush border membrane was found. We thus measured the hydrolysis activities toward Hyp-dipeptides in the cytosolic fraction of the small intestine and similar results were obtained.
Using the perfusion technique, several investigators have reported the digestion and assimilation of small oligopeptides in the small intestine. 17, 24, 26, 27) We also examined the absorption and assimilation of Hypdipeptides by using a vascular perfusion technique in the intestine. When Hyp-Gly and Pro-Hyp were injected into the jejunum, perfusate free Hyp did not increase, but the peptide form of Hyp was absorbed and gradually Crude material from the pooled perfusates was subjected to solid-phase extraction (SPE) with a Sep-Pak Light C18 cartridge. The crude peptide fraction eluted with 20% acetonitrile/H 2 O containing 0.1% TFA (10 ml) was applied to preparative HPLC in an ODS-3 column. The peptides were eluted with a linear gradient of acetonitrile (0 to 20%, v/v) containing 0.1% TFA, and six peaks with retention times of 17.3, 17.9, 20.9, 21.7, 24.1, and 25.7 min numbered 1 to 6 were manually collected. The synthetic pentadecapeptide, (Pro-Hyp-Gly) 5 , was injected into the jejunal lumen, and some peptides in the perfusate collected from the portal vein were analyzed by MALDI-TOF/TOF.
increased. In contrast, free Hyp increased rapidly and peptide form Hyp was also elevated in the case of the Ser-Hyp and Ala-Hyp perfusate. While there is no evidence to explain the activity of luminal digestive enzymes in the present experiment, the in situ absorption rates of the four dipeptides correspond well with the in vitro hydrolysis activities in the mucosal cell cytosol. In addition, more evidence is required to show that Hypdipeptides are transported in intact form by a paracellular route, one which would not involve peptide transport in the brush border or intercellular transport localized in the basolateral membrane. In transport studies on small oligopeptides, labelled compounds are often used and/or the measurement of substrates or products is carried out by HPLC analyses. 16, 17, 26, 27) The resolution and identification of Hyp-dipeptides by reversed-phase HPLC are not specific and sensitive. Therefore, we used LC-MS/MS analyses of the perfusates to check the level of intact dipeptide transport across the intestinal wall. Not only was the presence of each intact dipeptide identified, the absorption ratio of the dipeptide was calculated semi-quantitatively. While Ala-Hyp and Ser-Hyp were certainly identified in the perfusates in the intact form, Hyp-Gly was to a large extent absorbed solely in the intact form. This means that these Hyp-dipeptides escaped complete hydrolysis to the corresponding amino acids during intestinal digestion and assimilation. Moreover, we examined the digestion and assimilation of synthetic (Pro-Hyp-Gly) 5 in the perfused small intestine of rats. A trace amount of the intact form appeared in the perfusate, and several smaller Hyp-oligopeptides such as (Pro-Hyp-Gly) 4 and Gly-(Pro-Hyp-Gly) 3 were certainly transported across the intestinal wall. Pro-Hyp was to a large extent absorbed, but Hyp-Gly and Gly-Pro were not detected in the portal perfusate. These results on the intestinal assimilation of (Pro-Hyp-Gly) 5 indicate that the cleavage sites may mainly be the N-and C-terminal of the glycine residue. The dipeptide, Hyp-Gly, was resistant to enzymatic hydrolysis, but the Hyp-Gly sequence in (Pro-Hyp-Gly) 5 might be easily cleaved. This discrepancy cannot be explained and deserves further study.
It is generally assumed that, during absorption, proteins derived from foodstuffs are hydrolyzed, generating small peptides and amino acids in the lumen. These small peptides are then hydrolyzed by intracellular peptidases, leading to the appearance of digestive products, mainly as free amino acids, in the portal vein. In contrast, there is some evidence that the intestinal transport of peptides or macromolecules may give, to a small but significant extent, antigens or biologically active substances. [28] [29] [30] [31] [32] [33] Various positive affects of the oral administration of a gelatin and gelatin hydrolysate have been proposed. [4] [5] [6] [7] [8] The underlying mechanisms responsible for these effects have not been fully demonstrated. Shigemura et al. 34) have recently reported that Pro-Hyp, a food-derived collagen peptide in humans, might stimulate the growth of mouse skin fibroblasts. We thus assume that some bioactive oligopeptides are generally produced during digestion and assimilation in the intestine. In the present study, these results provided direct evidence for the transport of some Hyp-containing peptides across the intestinal wall. The absorption of Hyp-Gly and Pro-Hyp, the most abundant sequence in the alpha-chain of collagen, was shown to occur mainly in their intact forms. Other than those dipeptides, a small amount of (Pro-Hyp-Gly) 5 and its derivative also be absorbed intact. In addition, derivatives with large mass may have some biological activity. This study may contribute to elucidating the mechanisms involved in the beneficial effects of an oral administration of a gelatin hydrolysate.
